Clinical significance of up-regulated lncRNA NEAT1 in prognosis of ovarian cancer

European Review for Medical and Pharmacological Sciences

Volumn 20, Issue , 2016, Pages 3373-3377

  Chen, Z J ^a   Zhang, Z ^a   Xie, B B ^a   Zhang, H Y ^a  

^a LINYI PEOPLE'S HOSPITAL   (China)

Author keywords

LncRNAs; NEAT1; Ovarian cancer; Prognosis

Indexed keywords

LONG UNTRANSLATED RNA; LONG UNTRANSLATED RNA NEAT1; UNCLASSIFIED DRUG; NEAT1 LONG NON-CODING RNA, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISTANT METASTASIS; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIDDLE AGED; OVARY CANCER; OVERALL SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; TISSUE LEVEL; TUMOR VOLUME; UPREGULATION; GENETICS; KAPLAN MEIER METHOD; OVARY TUMOR; PROGNOSIS;

BIOMARKERS, TUMOR; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; OVARIAN NEOPLASMS; PROGNOSIS; RNA, LONG NONCODING; UP-REGULATION;

EID: 85017129769     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. TORRE LA, BRAY F, SIEGEL RL, FERLAY J, LORTET-TIEULENT J, JEMAL A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108.
2. YAN HC, FANG LS, XU J, QIU YY, LIN XM, HUANG HX, HAN QY. The identification of the biological characteristics of human ovarian cancer stem cells. Eur Rev Med Pharmacol Sci 2014;18:3497-3503.
3. RUSTIN G, VAN DER BURG M, GRIFFIN C, QIAN W, SWART AM. Early versus delayed treatment of relapsed ovarian cancer. Lancet 2011;377:380-381.
4. TSAI MC, MANOR O, WAN Y, MOSAMMAPARAST N, WANG JK, LAN F, SHI Y, SEGAL E, CHANG HY. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010;329:689-693.
5. TSAI MC, SPITALE RC, CHANG HY. Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res 2011;71:3-7.
6. RINN JL, KERTESZ M, WANG JK, SQUAZZO SL, XU X, BRUGMANN SA, GOODNOUGH LH, HELMS JA, FARNHAM PJ, SEGAL E, CHANG HY. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007;129:1311-1323.
7. QIU MT, HU JW, YIN R, XU L. Long noncoding RNA: an emerging paradigm of cancer research. Tumour Biol 2013;34:613-620.
8. ZHANG JH, WEI HW, YANG HG. Long noncoding RNA SNHG15, a potential prognostic biomarker for hepatocellular carcinoma. Eur Rev Med Pharmacol Sci 2016;20:1720-1724.
9. GUPTA RA, SHAH N, WANG KC, KIM J, HORLINGS HM, WONG DJ, TSAI MC, HUNG T, ARGANI P, RINN JL, WANG Y, BRZOSKA P, KONG B, LI R, WEST RB, VAN DE VIJVER MJ, SUKUMAR S, CHANG HY. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010;464:1071-1076.
10. ZHANG Q, GENG PL, YIN P, WANG XL, JIA JP, YAO J. Down-regulation of long non-coding RNA TUG1 inhibits osteosarcoma cell proliferation and promotes apoptosis. Asian Pac J Cancer Prev 2013;14:2311-2315.
11. QIU JJ, LIN YY, YE LC, DING JX, FENG WW, JIN HY, ZHANG Y, LI Q, HUA KQ. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer. Gynecol Oncol 2014;134:121-128.
12. ZHANG J, YIN XJ, XU CJ, NING YX, CHEN M, ZHANG H, CHEN SF, YAO LQ. The histone deacetylase SIRT6 inhibits ovarian cancer cell proliferation via down-regulation of Notch 3 expression. Eur Rev Med Pharmacol Sci 2015;19:818-824.
13. KNUTSON KL, KARYAMPUDI L, LAMICHHANE P, PRESTON C. Targeted immune therapy of ovarian cancer. Cancer Metastasis Rev 2015;34:53-74.
14. YANG G, LU X, YUAN L. LncRNA: a link between RNA and cancer. Biochim Biophys Acta 2014;1839:1097-1109.
15. SPIZZO R, ALMEIDA MI, COLOMBATTI A, CALIN GA. Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene 2012;31:4577-4587.
16. NAGANUMA T, HIROSE T. Paraspeckle formation during the biogenesis of long non-coding RNAs. RNA Biol 2013;10:456-461.
17. CHEN X, KONG J, MA Z, GAO S, FENG X. Up regulation of the long non-coding RNA NEAT1 promotes esophageal squamous cell carcinoma cell progression and correlates with poor prognosis. Am J Cancer Res 2015;5:2808-2815.
18. GUO S, CHEN W, LUO Y, REN F, ZHONG T, RONG M, DANG Y, FENG Z, CHEN G. Clinical implication of long non-coding RNA NEAT1 expression in hepatocellular carcinoma patients. Int J Clin Exp Pathol 2015;8:5395-5402
19. CHAI Y, LIU J, ZHANG Z, LIU L. HuR-regulated lncRNA NEAT1 stability in tumorigenesis and progression of ovarian cancer. Cancer Med 2016;5:1588-1598.